We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 707

Supreme Court Will Judge Biosimilar Patent Dance
  • Foley & Lardner LLP
  • USA
  • January 16 2017

The U.S. Supreme Court has agreed to review some of the patent dispute resolution provisions of the Biologics Price Competition and Innovation Act


Federal Circuit Questions Standing For IPR Appeals
  • Foley & Lardner LLP
  • USA
  • January 11 2017

As I have written previously, neither the statutes nor the regulations governing Inter Partes Review (IPR) require the party challenging the patent


Federal Circuit Finds IPR Petitioner Lacks Standing To Appeal
  • Foley & Lardner LLP
  • USA
  • January 10 2017

Yesterday in Phigenix, Inc. v. Immunogen, Inc., the Federal Circuit held that petitioner Phigenix lacked standing to appeal an adverse final written


District Court Dismisses USPTO December 2015 Holidays Case
  • Foley & Lardner LLP
  • USA
  • December 20 2016

On December 2, 2016, Judge O’Grady of the U.S. District Court for the Eastern District of Virginia granted the USPTO’s motion to dismiss the


U.S. Supreme Court Grants Certiorari to Review Patent Venue Statute
  • Foley & Lardner LLP
  • USA
  • December 15 2016

On December 14, 2016, the Supreme Court granted certiorari in TC Heartland, LLC v. Kraft Foods Group Brands LLC. The question presented is: Whether


Reduced Scope of Post-IPR Estoppel Imperils Litigation Stays
  • Foley & Lardner LLP
  • USA
  • December 14 2016

In Depomed, Inc. v. Purdue Pharma LP et al., 3-13-cv-00571 (NJD November 4, 2016, Mem. Op. Dkt. 238) (Bongiovanni, MJ), the Court analyzed and


Solicitor General Sides With Sandoz On Interpretation Of Biosimilar Statute
  • Foley & Lardner LLP
  • USA
  • December 13 2016

The Solicitor General of the United States has filed an amicus brief in Sandoz Inc. v. Amgen Inc., asking the Supreme Court to grant certiorari and


Supreme Court Complicates Design Patent Damage Calculation - Apple v. Samsung
  • Foley & Lardner LLP
  • USA
  • December 6 2016

On December 6, 2016, the Supreme Court issued a rare unanimous decision on the issue of damages for design patent infringement that continues the


PTAB Holds Oral Hearings In Tecfidera Patent IPR and Interference
  • Foley & Lardner LLP
  • USA
  • December 6 2016

On November 30, 2016, the USPTO Patent Trial and Appeal Board (PTAB) held oral hearings in two different inter partes proceedings involving the


Swearing Behind A Reference With Reasonably Continuous Diligence
  • Foley & Lardner LLP
  • USA
  • November 16 2016

In Perfect Surgical Techniques, Inc. v. Olympus America, Inc., the Federal Circuit vacated and remanded a USPTO Patent Trial and Appeal Board